Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws. For any such use, please visit NBC NEWS Archives XPRESS.
(Studio) Report introduced
REPORTER: Tom Brokaw
(Dallas, Texas) Authorities' concern over appearance of new designer drug, dubbed Eve, an amphetamine-like drug with growing popularity examined; scenes shown. [USER - describes drug's effect.] Similarity between Eve and recently-outlawed drug Ecstasy noted. [FDA (Food and Drug Administration) chemist Jack ROSENSTEIN - explains molecular difference between the two drugs.] [Dealer "RONNIE" - considers basis of drug's popularity as status symbol.] [Dr. Bernard GOTHELF - explains risk of brain damage.] [DEA spokesperson Philip JORDAN - cites inability to do anything.] [USER - compares Eve with Ecstasy.]
REPORTER: Robert Elliot
- Brokaw, Tom;
- Elliot, Robert
Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.
Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:
- You may request a loan of this video by registering on our website and placing an order.
- You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
- If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.
If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.